|Articles|February 15, 2002
- BioPharm International-02-01-2002
- Volume 15
- Issue 2
Using a Model and Tools to Standardize the Preparation for a Preapproval Inspection
Author(s)Barbara Unger
By Barara W. Unger, Don Hill Associates, Inc., pp. 14-18, 71. An effective, well-developed, and versatile preapproval inspection model focuses management and inspectors on conclusions, minimizes process reinvention, and tracks inspection readiness, especially when you are using a contract manufacturer.
Advertisement
Articles in this issue
almost 24 years ago
Sale of Your Product Can Prevent Patenting: How to Avoid the On-Sale Baralmost 24 years ago
Outsourcing Outlook: Reaping the Benefits of E-Procurementalmost 24 years ago
The Immunogenicity of Therapeutic Proteinsalmost 24 years ago
Analytical Advances: Calibration Management of Outsourced Calibrationsalmost 24 years ago
Inside Washington: Costs and Controls Challenge Manufacturersalmost 24 years ago
21 CFR Part 11: (Un)Expected Added ValueNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
2
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
3
Implementing Automation and Flexible Design for Allogeneic Manufacturing
4
Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows
5
